STOCK TITAN

Absci Corp (ABSI) director Menelas Pangalos buys 75,095 shares in market

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Absci Corp director buys additional shares on the open market. Director Menelas N. Pangalos purchased 75,095 shares of Absci Corp common stock in an open-market transaction at a price of $2.74 per share. After this purchase, he directly owns 189,055 common shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pangalos Menelas N

(Last) (First) (Middle)
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BOULEVARD

(Street)
VANCOUVER WA 98683

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 P(1) 75,095 A $2.74 189,055 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Open market purchase of shares in accordance with Issuer's trading policies.
Remarks:
/s/ Shelby Walker, attorney-in-fact 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Absci Corp (ABSI) report in this Form 4?

Absci Corp reported that director Menelas N. Pangalos bought 75,095 shares of common stock. The shares were acquired in an open-market purchase at $2.74 per share, increasing his directly owned stake to 189,055 shares.

Who is the insider involved in the latest Absci Corp (ABSI) share purchase?

The insider is Menelas N. Pangalos, a director of Absci Corp. He executed an open-market purchase of 75,095 common shares, bringing his directly held ownership position to a total of 189,055 shares after the reported transaction.

How many Absci Corp (ABSI) shares did the director buy and at what price?

Director Menelas N. Pangalos bought 75,095 Absci Corp common shares at $2.74 per share. This open-market transaction increased his direct holdings to 189,055 shares following completion of the purchase reported in the filing.

What is Menelas N. Pangalos’s total Absci Corp (ABSI) ownership after the transaction?

After the reported trade, director Menelas N. Pangalos directly owns 189,055 Absci Corp common shares. This reflects his open-market purchase of 75,095 shares at $2.74 per share disclosed in the Form 4 insider transaction report.

Was the Absci Corp (ABSI) insider transaction an open-market purchase or another type?

The reported insider transaction was an open-market purchase of common stock. Director Menelas N. Pangalos bought 75,095 shares at $2.74 per share, consistent with the company’s trading policies as referenced in the Form 4 footnote.
Absci Corp

NASDAQ:ABSI

View ABSI Stock Overview

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

377.43M
130.23M
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER